Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis
NCT00748410
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class
Stopped
SB-656933 is no longer being developed for ulcerative colitis.
Conditions
Colitis, Ulcerative
Interventions
DRUG:
SB-656933
Sponsor
GlaxoSmithKline